Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquisitionYear |
2004
|
| gptkbp:countryOfOrigin |
gptkb:United_States
|
| gptkbp:fate |
acquired by CSL Limited
|
| gptkbp:headquartersLocation |
gptkb:King_of_Prussia,_Pennsylvania,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aventis Behring
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:parentCompany |
gptkb:Aventis
|
| gptkbp:predecessor |
gptkb:Centeon
|
| gptkbp:product |
albumin
immunoglobulins plasma-derived therapies coagulation factors protein therapies |
| gptkbp:successor |
gptkb:CSL_Behring
|
| gptkbp:bfsParent |
gptkb:CSL_Behring
|
| gptkbp:bfsLayer |
6
|